VARGAS MEJIA, MIGUEL ANGEL

VARGAS MEJIA, MIGUEL ANGEL

INVESTIGACIÓN MÉDICA · Nivel 2

Información*

Nombre MIGUEL ANGEL VARGAS MEJIA
Área BIOLOGÍA Y QUÍMICA
Campo INVESTIGACIÓN MÉDICA
Disciplina FARMACOLOGÍA HUMANA
Especialidad FARMACOONCOLOGIA
CVU 33773
Institución
Dependencia DEPARTAMENTO DE BIOMEDICINA MOLECULAR
Entidad CIUDAD DE MEXICO
Nivel 2
Vigencia Inicio: 01/01/2023
Fin: 31/12/2027

* Información del primer trimestre de 2026.
Fuente: SECIHTI.

Publicaciones ORCID

2025
MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells International Journal of Molecular Sciences
DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review International Journal of Molecular Sciences
2023
Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico International Journal of Molecular Sciences
2022
<sup>131</sup>I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry Molecules
2021
H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinoma. Oncogene
Development of <sup>177</sup>Lu-DN(C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer. Journal of biomedical nanotechnology
Structural Insight of the Anticancer Properties of Doxazosin on Overexpressing EGFR/HER2 Cell Lines Breast Cancer
2020
A class I histone deacetylase is implicated in the encystation of Entamoeba invadens. International journal for parasitology
KRas4BG12C/D/PDE6δ Heterodimeric Molecular Complex: A Target Molecular Multicomplex for the Identification and Evaluation of Nontoxic Pharmacological Compounds for the Treatment of Pancreatic Cancer Challenges in Pancreatic Cancer
2019
Molecular mechanism of the association and dissociation of Deltarasin from the heterodimeric KRas4B-PDEδ complex. Biopolymers